| # | Title | Journal | Year | Citations |
|---|
| 1 | Mortality in Mental Disorders and Global Disease Burden Implications | JAMA Psychiatry | 2015 | 2,059 |
| 2 | Epidemiology ofDSM-5Alcohol Use Disorder | JAMA Psychiatry | 2015 | 1,995 |
| 3 | Large-Scale Network Dysfunction in Major Depressive Disorder | JAMA Psychiatry | 2015 | 1,517 |
| 4 | A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression | JAMA Psychiatry | 2013 | 1,314 |
| 5 | Prevalence, Correlates, and Treatment of Lifetime Suicidal Behavior Among Adolescents | JAMA Psychiatry | 2013 | 1,241 |
| 6 | The Psychosis High-Risk State | JAMA Psychiatry | 2013 | 1,222 |
| 7 | Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States | JAMA Psychiatry | 2018 | 1,107 |
| 8 | Identification of a Common Neurobiological Substrate for Mental Illness | JAMA Psychiatry | 2015 | 1,050 |
| 9 | Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013 | JAMA Psychiatry | 2017 | 1,006 |
| 10 | The Changing Face of Heroin Use in the United States | JAMA Psychiatry | 2014 | 996 |
| 11 | Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013 | JAMA Psychiatry | 2015 | 851 |
| 12 | Adult Psychiatric Outcomes of Bullying and Being Bullied by Peers in Childhood and Adolescence | JAMA Psychiatry | 2013 | 830 |
| 13 | Premature Mortality Among Adults With Schizophrenia in the United States | JAMA Psychiatry | 2015 | 770 |
| 14 | Onset Timing, Thoughts of Self-harm, and Diagnoses in Postpartum Women With Screen-Positive Depression Findings | JAMA Psychiatry | 2013 | 738 |
| 15 | Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects | JAMA Psychiatry | 2014 | 727 |
| 16 | Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive Episodes | JAMA Psychiatry | 2015 | 700 |
| 17 | Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm? | JAMA Psychiatry | 2020 | 691 |
| 18 | Epidemiology ofDSM-5Drug Use Disorder | JAMA Psychiatry | 2016 | 675 |
| 19 | Schizophrenia Is a Cognitive Illness | JAMA Psychiatry | 2013 | 649 |
| 20 | Agreement Between Prospective and Retrospective Measures of Childhood Maltreatment | JAMA Psychiatry | 2019 | 648 |
| 21 | Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder | JAMA Psychiatry | 2021 | 648 |
| 22 | Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life | JAMA Psychiatry | 2014 | 638 |
| 23 | Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review | JAMA Psychiatry | 2016 | 621 |
| 24 | Abnormal Rich Club Organization and Functional Brain Dynamics in Schizophrenia | JAMA Psychiatry | 2013 | 594 |
| 25 | A Smartphone Application to Support Recovery From Alcoholism | JAMA Psychiatry | 2014 | 585 |
| 26 | Benzodiazepine Use in the United States | JAMA Psychiatry | 2015 | 582 |
| 27 | Meta-analysis of Functional Magnetic Resonance Imaging Studies of Inhibition and Attention in Attention-deficit/Hyperactivity Disorder | JAMA Psychiatry | 2013 | 580 |
| 28 | Schizophrenia—An Overview | JAMA Psychiatry | 2020 | 569 |
| 29 | Efficacy of Self-guided Internet-Based Cognitive Behavioral Therapy in the Treatment of Depressive Symptoms | JAMA Psychiatry | 2017 | 560 |
| 30 | Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse | JAMA Psychiatry | 2016 | 558 |
| 31 | The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders | JAMA Psychiatry | 2017 | 547 |
| 32 | Comorbidities and Mortality in Bipolar Disorder | JAMA Psychiatry | 2013 | 535 |
| 33 | Relative Efficacy of Mindfulness-Based Relapse Prevention, Standard Relapse Prevention, and Treatment as Usual for Substance Use Disorders | JAMA Psychiatry | 2014 | 535 |
| 34 | Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood | JAMA Psychiatry | 2019 | 519 |
| 35 | Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis | JAMA Psychiatry | 2018 | 516 |
| 36 | Salience Network–Based Classification and Prediction of Symptom Severity in Children With Autism | JAMA Psychiatry | 2013 | 510 |
| 37 | Lifetime Prevalence, Age of Risk, and Genetic Relationships of Comorbid Psychiatric Disorders in Tourette Syndrome | JAMA Psychiatry | 2015 | 496 |
| 38 | Traffic-Related Air Pollution, Particulate Matter, and Autism | JAMA Psychiatry | 2013 | 495 |
| 39 | Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy | JAMA Psychiatry | 2013 | 491 |
| 40 | The Experience of Symptoms of Depression in Men vs Women | JAMA Psychiatry | 2013 | 490 |
| 41 | The Sertraline vs Electrical Current Therapy for Treating Depression Clinical Study | JAMA Psychiatry | 2013 | 489 |
| 42 | Association of Symptom Network Structure With the Course of Depression | JAMA Psychiatry | 2015 | 482 |
| 43 | Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression | JAMA Psychiatry | 2019 | 472 |
| 44 | Maternal Depression During Pregnancy and the Postnatal Period | JAMA Psychiatry | 2013 | 467 |
| 45 | Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder | JAMA Psychiatry | 2014 | 466 |
| 46 | Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia | JAMA Psychiatry | 2017 | 460 |
| 47 | Dialectical Behavior Therapy for High Suicide Risk in Individuals With Borderline Personality Disorder | JAMA Psychiatry | 2015 | 457 |
| 48 | Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder | JAMA Psychiatry | 2013 | 455 |
| 49 | Efficacy of Psychotherapies for Borderline Personality Disorder | JAMA Psychiatry | 2017 | 454 |
| 50 | Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression | JAMA Psychiatry | 2018 | 451 |
